Brief: 9 Meters Biopharma- Agreement With Ebris To Continue Evaluation Of Larazotide For Covid-19 Respiratory Complications

9 Meters Biopharma

21/12/2020 16:58

Dec 21 (Reuters) - 9 Meters Biopharma Inc  NMTR.O :
    * 9 METERS BIOPHARMA - AGREEMENT WITH EBRIS TO CONTINUE
EVALUATION
OF LARAZOTIDE FOR COVID-19 RESPIRATORY COMPLICATIONS
    * 9 METERS BIOPHARMA INC - EBRIS WILL ADVANCE LARAZOTIDE
INTO AN
AUSTRALIAN INVESTIGATIONAL NEW DRUG
    * 9 METERS BIOPHARMA INC - PHASE 1 STUDY OF LARAZOTIDE
EXPECTED TO
BEGIN IN 2021

Source text: https://bit.ly/3h7REU3
Further company coverage:  NMTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))